Statin hyporesponders may have blocked arteries
the ONA take:
According to a new study published in the journal Arteriosclerosis, Thrombosis and Vascular Biology, researchers have found that if a patient's low density lipoprotein (LDL), or "bad cholesterol," stays the same or increases after taking statin medications, the patient may have more blocked arteries compared with patients whose LDL decreases.
For the study, researchers from the South Australian Health & Medical Research Institute in Adelaide, Australia, analyzed data from seven studies that included 647 patients diagnosed with coronary artery disease who took statin medications, such as simvastatin, atorvastatin, and rosuvastatin, to help decrease LDL.
In all of the studies, patients' arteries were studied with ultrasound before and after statin treatment. Results showed that the 20% of patients considered statin hyporesponders (their LDL cholesterol levels decreased a little, stayed the same, or increased) experienced more plaque accumulation in their arteries compared with patients who responded to statin therapy.
Researchers found among the statin hyporesponders, 79% were men with an average age of 56 years, while 66% were men with an average age of 58 years among statin responders.
Low density lipoprotein, or "bad cholesterol," stays the same or increases after taking statin medications.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|